Folia Medica (Oct 2022)

Central retinal artery occlusion in a patient with sickle cell disease treated with recombinant tissue plasminogen activator

  • Slaven Pikija,
  • Marieta V. Peycheva,
  • Rousan Aghayan-Ugurluoglu,
  • Bernhard Ganser,
  • Eugen Trinka

DOI
https://doi.org/10.3897/folmed.64.e67881
Journal volume & issue
Vol. 64, no. 5
pp. 840 – 843

Abstract

Read online Read online Read online

Central retinal artery occlusion is a rare ophthalmological complication of sickle cell disease, usually provoked by additional contributing risk factors and its treatment remains controversial. We describe a patient with sickle cell disease and a spontaneous central retinal artery occlusion of his left eye that probably has good result from intravenous thrombolysis. We want to add sickle cell disease as rare etiological cause of central retinal artery occlusion and perpetuate evidence of intravenous recombinant tissue plasminogen activator administration in this condition.